What is the treatment of choice for mild to moderate bacterial conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The treatment of choice for mild to moderate bacterial conjunctivitis is a 5- to 7-day course of a broad-spectrum topical antibiotic, as it is associated with earlier clinical and microbiological remission compared to placebo 1. When selecting a topical antibiotic, the most convenient or least expensive option can be chosen, as there is no clinical evidence suggesting the superiority of any particular antibiotic 1. Some commonly used broad-spectrum topical antibiotics for bacterial conjunctivitis include:

  • Erythromycin ointment
  • Polymyxin B-trimethoprim drops
  • Fluoroquinolones like moxifloxacin or ciprofloxacin The typical regimen involves applying drops 4 times daily or ointment 2-3 times daily for 5-7 days, even if symptoms resolve earlier to ensure complete eradication of the infection. It's also important to note that povidone-iodine 1.25% ophthalmic solution may be as effective as topical antibiotic therapy for treating bacterial conjunctivitis and could be considered when access to antibiotics is limited 1. In addition to antibiotic treatment, patients should:
  • Temporarily discontinue contact lens wear until the infection resolves completely
  • Gently clean away any discharge with warm water and a clean cloth before applying medication
  • Apply medication as directed, even if symptoms resolve earlier, to ensure complete eradication of the infection.

From the FDA Drug Label

Moxifloxacin ophthalmic solution, 0.5% is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:

Moxifloxacin ophthalmic solution is for topical ophthalmic use.

Instill one drop in the affected eye 3 times a day for 7 days.

The treatment of choice for mild to moderate bacterial conjunctivitis is moxifloxacin ophthalmic solution, 0.5%, administered as one drop in the affected eye 3 times a day for 7 days 2.

From the Research

Treatment Options for Mild to Moderate Bacterial Conjunctivitis

  • The treatment of choice for mild to moderate bacterial conjunctivitis is a broad-spectrum antibiotic, with fluoroquinolones being a popular option 3, 4, 5.
  • Moxifloxacin 0.5% ophthalmic solution has been shown to be effective in the treatment of bacterial conjunctivitis, with good activity against various Gram-positive and -negative ocular isolates 4, 5.
  • Gatifloxacin 0.5% ophthalmic solution administered twice daily for 5 days has also been found to be safe and effective for the treatment of acute bacterial conjunctivitis 6.
  • Other antibiotics such as gentamycin, tobramycin, and azithromycin may be preferred in some cases, and delayed topical antibiotics or treatment without antibiotics using artificial tears and eye bathings may be considered in mild cases 7.

Factors Influencing Treatment Choice

  • The development of resistance to antibiotics is a concern, and fluoroquinolones should be saved for severe infections due to their broad spectrum of activity 3, 7.
  • The choice of antibiotic may depend on the severity of the infection, the patient's age and health status, and the presence of any underlying conditions 5, 7.
  • Topical antibiotics are generally preferred over systemic antibiotics for the treatment of bacterial conjunctivitis, as they provide high concentrations of the antibiotic at the site of infection and minimize systemic side effects 4, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Limitations of current antibiotics for the treatment of bacterial conjunctivitis.

Optometry and vision science : official publication of the American Academy of Optometry, 2010

Research

Gatifloxacin 0.5% administered twice daily for the treatment of acute bacterial conjunctivitis in patients one year of age or older.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2014

Research

[Bacterial conjunctivitis--diagnosis and therapy update].

Klinische Monatsblatter fur Augenheilkunde, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.